Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Obesity-associated hypertension: new insights into mechanisms Rahmouni K; Correia ML; Haynes WG; Mark ALHypertension 2005[Jan]; 45 (1): 9-14Obesity is strongly associated with hypertension and cardiovascular disease. Several central and peripheral abnormalities that can explain the development or maintenance of high arterial pressure in obesity have been identified. These include activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system. Obesity is also associated with endothelial dysfunction and renal functional abnormalities that may play a role in the development of hypertension. The continuing discovery of mechanisms regulating appetite and metabolism is likely to lead to new therapies for obesity-induced hypertension. Better understanding of leptin signaling in the hypothalamus and the mechanisms of leptin resistance should facilitate therapeutic approaches to reverse the phenomenon of selective leptin resistance. Other hunger and satiety signals such as ghrelin and peptide YY are potentially attractive therapeutic strategies for treatment of obesity and its complications. These recent discoveries should lead to novel strategies for treatment of obesity and hypertension.|Adiponectin[MESH]|Aldosterone/physiology[MESH]|Animals[MESH]|Appetite/physiology[MESH]|Endothelium, Vascular/physiopathology[MESH]|Energy Metabolism/physiology[MESH]|Ghrelin[MESH]|Humans[MESH]|Hyperinsulinism/physiopathology[MESH]|Hypertension/*etiology/physiopathology[MESH]|Intercellular Signaling Peptides and Proteins/physiology[MESH]|Kidney/physiopathology[MESH]|Leptin/physiology[MESH]|Mice[MESH]|Mice, Mutant Strains[MESH]|Mineralocorticoid Receptor Antagonists/pharmacology[MESH]|Obesity/*complications/physiopathology[MESH]|Peptide Hormones/physiology[MESH]|Peptide YY/physiology[MESH]|Receptors, Cell Surface/physiology[MESH]|Receptors, Leptin[MESH]|Renin-Angiotensin System/physiology[MESH]|Repressor Proteins/physiology[MESH]|Satiation/physiology[MESH]|Suppressor of Cytokine Signaling 3 Protein[MESH]|Suppressor of Cytokine Signaling Proteins[MESH]|Sympathetic Nervous System/physiopathology[MESH]|Transcription Factors/physiology[MESH] |